Janney Montgomery Scott LLC Insmed Inc Transaction History

Janney Montgomery Scott LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 26, 2023	BUY	$16.44 - $21.1 $66,828 - $85,771	4,065 Added 24.36%	20,753 $438,000
Q1 2023 Apr 28, 2023	BUY	$16.26 - $21.73 $33,999 - $45,437	2,091 Added 14.32%	16,688 $285,000
Q4 2022 Feb 01, 2023	BUY	$16.98 - $23.15 $35,793 - $48,800	2,108 Added 16.88%	14,597 $292,000
Q3 2022 Oct 25, 2022	SELL	$20.88 - $28.21 $28,522 - $38,534	-1,366 Reduced 9.86%	12,489 $269,000
Q2 2022 Aug 03, 2022	BUY	$17.07 - $25.71 $34,908 - $52,576	2,045 Added 17.32%	13,855 $276,000
Q1 2022 May 04, 2022	BUY	$20.42 - $28.13 $67,161 - $92,519	3,289 Added 38.6%	11,810 $278,000
Q4 2021 Jan 27, 2022	SELL	$25.89 - $33.45 $10,304 - $13,313	-398 Reduced 4.46%	8,521 $232,000
Q3 2021 Oct 29, 2021	SELL	$22.46 - $29.47 $19,225 - $25,226	-856 Reduced 8.76%	8,919 $246,000
Q2 2021 Jul 26, 2021	BUY	$24.17 - $36.01 $236,261 - $351,997	9,775 New	9,775 $278,000

467

182M

2.27M

3.33M

Ticker INSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 135,476,992
Market Cap $10B
Description
Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.